 ANN ARBOR, MI ACCESSWIRE May 4, 2021 ENDRA Life Sciences Inc. NASDAQ:NDRA, a pioneer of Thermo Acoustic Enhanced UltraSound TAEUS, announces the Company has recently been issued U.S. Patent 10993624 the 624 patent Systems And Methods For Thermoacoustic Transducer Optimization and U.S. Patent 10996163 the 163 patent Acoustically Isolated Thermoacoustic Imaging Probe and Process of Manufacture from the United States Patent Trademark Office USPTO. The TAEUS transducer serves to receive thermoacoustic ultrasound signals, and the 624 patent provides a tool for developing and adjusting the TAEUS probe and its transducer functionality to maximize the amount of information extracted from a subject. 